Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

Venous Thrombosis III: Interprofessional Care

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Low thermal inertia of carbonaceous asteroid Bennu driven by cracks observed in returned samples.

Nature communications·2026

Same author

Baboon travel progressions as a "social spandrel" in collective animal behaviour.

Behavioral ecology : official journal of the International Society for Behavioral Ecology·2025

Same author

An evaporite sequence from ancient brine recorded in Bennu samples.

Nature·2025

Same author

A literature review and evidence-based evaluation of the Dutch national immunisation schedule yield possibilities for improvements.

Vaccine: X·2024

Same author

Childhood adversities and risk of posttraumatic stress disorder and major depression following a motor vehicle collision in adulthood.

Epidemiology and psychiatric sciences·2023

Same author

Formation and evolution of carbonaceous asteroid Ryugu: Direct evidence from returned samples.

Science (New York, N.Y.)·2022

Search research articles

Related Experiment Videos

Anticoagulation therapy in glaucoma surgery.

A Alwitry¹, A J King, S A Vernon

¹Eye, Ear, Nose and Throat Centre, Queens Medical Centre, Nottingham, UK.

Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie

|April 9, 2008

Summary

This summary is machine-generated.

Most glaucoma surgeons in England do not stop warfarin or aspirin before surgery. Practices vary widely for managing anticoagulant therapy during glaucoma surgery, with limited guidance available.

Related Experiment Videos

Area of Science:

Ophthalmology
Cardiology
Pharmacology

Background:

Glaucoma surgery requires careful perioperative management, especially for patients on anticoagulants.
Warfarin and acetylsalicylic acid (aspirin) are commonly used anticoagulants that pose bleeding risks during surgery.

Purpose of the Study:

To investigate the current practices of ophthalmologists regarding anticoagulant management during glaucoma surgery.
To identify variations in perioperative strategies for patients on warfarin or aspirin.

Main Methods:

A questionnaire survey was distributed to glaucoma specialists in England.
The survey assessed the perioperative management of patients undergoing glaucoma surgery while on warfarin or aspirin.

Main Results:

A 68.8% response rate was achieved from 64 participating glaucoma surgeons.
Only 32.8% of surgeons routinely stopped warfarin, with a mean cessation of 4 days prior to surgery.
81.25% of surgeons preferred operating at an INR of 3 or below, while 31.2% routinely stopped aspirin.

Conclusions:

The majority of glaucoma surgeons do not routinely discontinue warfarin or aspirin before surgery.
Significant diversity exists in the management of anticoagulant therapy among English glaucoma surgeons.
There is a lack of definitive evidence-based guidance for managing these medications perioperatively.